background image

Paid Clinical Trials Oklahoma City

Discover 606 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Featured

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 10 - 17

Code: NCT06372964

Phase3, Recruiting
Active & Responsive

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: 21 recruiting locations
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT05787587

Phase1, Recruiting
Active & Responsive

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: 89 recruiting locations
Sponsor: Cleerly, Inc.

Sex: All

Age: 55+

Code: NCT06112418

Recruiting
Active & Responsive

Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant

for
Sensori-Neural Deafness, Sensorineural Hearing Loss,
Location: 7 recruiting locations
Sponsor: Envoy Medical Corporation

Sex: All

Age: 18+

Code: NCT06699797

Recruiting
Active & Responsive

53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

for
Osteoarthritis (OA) of the Knee
Location: 24 recruiting locations
Sponsor: OrthoTrophix, Inc

Sex: All

Age: 50 - 70+

Code: NCT06865079

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Fenofibrate for Prevention of DR Worsening

for
Diabetic Retinopathy
Location: 58 recruiting locations
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18 - 70+

Code: NCT04661358

Phase3, Recruiting
Active & Responsive

P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety

for
ADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
Location: 44 recruiting locations
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18 - 65

Code: NCT06973577

Phase3, Recruiting
Active & Responsive

A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

for
Depressive Disorder, Major
Location: 30 recruiting locations
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 64

Code: NCT06785012

Phase2, Recruiting
Active & Responsive

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

for
Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma
Location: 6 recruiting locations
Sponsor: Phanes Therapeutics

Sex: All

Age: 18+

Code: NCT05431270

Phase1, Phase2, Recruiting
Active & Responsive

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

for
Solid Tumor Malignancies, Brain Metastases From Solid Tumors
Location: 5 recruiting locations
Sponsor: A2A Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06136884

Phase1, Recruiting